PRKDC and neoplasm: The expression of DNA‐PK and functional markers of MDSCs (iNOS, Arg1, and IDO) in splenic MDSCs from tumor‐bearing mice treated with NU7441 in vivo was significantly increased (Figure S10A–D), which was consistent with the results of NU7441 administration in vitro.